Table of Content

1 Radiopharmaceutical Market Introduction and Overview
1.1 Radiopharmaceutical Definition
1.2 Research Purposes
1.3 Report Timeline
1.4 Economic Analysis of Global Regions
1.5 Inflation Analysis
1.6 The Impact of the Russian-Ukrainian War on the Market
1.7 Coronavirus Disease 2020 (COVID-19) Impact on Global
2 Global Radiopharmaceutical Historical Market Analysis by Type
2.1 Market Size Analysis by Types
2.2 Global Radiopharmaceutical Revenue and Market Share by Type
3 Global Radiopharmaceutical Historical Market Analysis by Application
3.1 Market Size Analysis by Application
3.2 Global Radiopharmaceutical Revenue Market Share by Application (2019-2024)
4 Global Market Growth Trends Analysis
4.1 Global Radiopharmaceutical Market Size (2019-2024)
4.2 Radiopharmaceutical Growth Trends Analysis by Regions
4.2.1 Radiopharmaceutical Market Size by Regions: 2019 VS 2024 VS 2030
4.2.2 Radiopharmaceutical Historic Revenue Market Size by Regions (2019-2024)
4.2.3 North America Radiopharmaceutical Market Size (2019-2024)
4.2.4 Europe Radiopharmaceutical Market Size (2019-2024)
4.2.5 Asia-Pacific Radiopharmaceutical Market Size (2019-2024)
4.2.6 Latin America Radiopharmaceutical Market Size (2019-2024)
4.2.7 Middle East & Africa Radiopharmaceutical Market Size (2019-2024)
5 North America
5.1 North America Radiopharmaceutical Revenue by Countries
5.1.1 North America Radiopharmaceutical Revenue by Countries (2019-2024)
5.2 North America Radiopharmaceutical Revenue by Types
5.3 North America Radiopharmaceutical Revenue by Applications
5.4 United States
5.5 Canada
6 Asia Pacific
6.1 Asia Pacific Radiopharmaceutical Revenue by Countries
6.1.1 Asia Pacific Radiopharmaceutical Revenue by Countries (2019-2024)
6.2 Asia Pacific Radiopharmaceutical Revenue by Types
6.3 Asia Pacific Radiopharmaceutical Revenue by Applications
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Radiopharmaceutical Revenue by Countries
7.1.1 Europe Radiopharmaceutical Revenue by Countries (2019-2024)
7.2 Europe Radiopharmaceutical Revenue by Types
7.3 Europe Radiopharmaceutical Revenue by Applications
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Nordic
8 Latin America
8.1 Latin America Radiopharmaceutical Revenue by Countries
8.1.1 Latin America Radiopharmaceutical Revenue by Countries (2019-2024)
8.2 Latin America Radiopharmaceutical Revenue by Types
8.3 Latin America Radiopharmaceutical Revenue by Applications
8.4 Brazil
8.5 Argentina
8.6 Mexico
9 Middle East & Africa
9.1 Middle East & Africa Radiopharmaceutical Revenue by Countries
9.1.1 Middle East & Africa Radiopharmaceutical Revenue by Countries (2019-2024)
9.2 Middle East & Africa Radiopharmaceutical Revenue by Types
9.3 Middle East & Africa Radiopharmaceutical Revenue by Applications
9.4 Egypt
9.5 South Africa
9.6 UAE
9.7 Turkey
9.8 Saudi Arabia
10 Global Radiopharmaceutical Market Competition, by Players
10.1 Global Radiopharmaceutical Revenue and Market Share by Players
10.2 Market Concentration Rate
10.2.1 Top 3 Radiopharmaceutical Players Market Share in 2023
10.2.2 Top 6 Radiopharmaceutical Players Market Share in 2023
10.2.3 Market Competition Trend
10.3 Radiopharmaceutical Players Head Office, Business Provided
10.4 Radiopharmaceutical Mergers & Acquisitions
10.5 Radiopharmaceutical New Entrants and Expansion Plans
11 Players Profiles11.1 Bayer
11.1.1 Bayer Company Profile
11.1.2 Radiopharmaceutical Product Overview
11.1.3 Bayer Radiopharmaceutical Market Performance (2019-2024)
11.1.4 Bayer Business Overview
11.1.5 Recent Developments and Plans
11.2 Triad Isotopes
11.2.1 Triad Isotopes Company Profile
11.2.2 Radiopharmaceutical Product Overview
11.2.3 Triad Isotopes Radiopharmaceutical Market Performance (2019-2024)
11.2.4 Triad Isotopes Business Overview
11.2.5 Recent Developments and Plans
11.3 Lantheus
11.3.1 Lantheus Company Profile
11.3.2 Radiopharmaceutical Product Overview
11.3.3 Lantheus Radiopharmaceutical Market Performance (2019-2024)
11.3.4 Lantheus Business Overview
11.3.5 Recent Developments and Plans
11.4 GE Healthcare
11.4.1 GE Healthcare Company Profile
11.4.2 Radiopharmaceutical Product Overview
11.4.3 GE Healthcare Radiopharmaceutical Market Performance (2019-2024)
11.4.4 GE Healthcare Business Overview
11.4.5 Recent Developments and Plans
11.5 Mallinckrodt
11.5.1 Mallinckrodt Company Profile
11.5.2 Radiopharmaceutical Product Overview
11.5.3 Mallinckrodt Radiopharmaceutical Market Performance (2019-2024)
11.5.4 Mallinckrodt Business Overview
11.5.5 Recent Developments and Plans
11.6 Eli Lilly
11.6.1 Eli Lilly Company Profile
11.6.2 Radiopharmaceutical Product Overview
11.6.3 Eli Lilly Radiopharmaceutical Market Performance (2019-2024)
11.6.4 Eli Lilly Business Overview
11.6.5 Recent Developments and Plans
11.7 Bracco Imaging
11.7.1 Bracco Imaging Company Profile
11.7.2 Radiopharmaceutical Product Overview
11.7.3 Bracco Imaging Radiopharmaceutical Market Performance (2019-2024)
11.7.4 Bracco Imaging Business Overview
11.7.5 Recent Developments and Plans
11.8 SIEMENS
11.8.1 SIEMENS Company Profile
11.8.2 Radiopharmaceutical Product Overview
11.8.3 SIEMENS Radiopharmaceutical Market Performance (2019-2024)
11.8.4 SIEMENS Business Overview
11.8.5 Recent Developments and Plans
11.9 Navidea
11.9.1 Navidea Company Profile
11.9.2 Radiopharmaceutical Product Overview
11.9.3 Navidea Radiopharmaceutical Market Performance (2019-2024)
11.9.4 Navidea Business Overview
11.9.5 Recent Developments and Plans
11.10 Nordion
11.10.1 Nordion Company Profile
11.10.2 Radiopharmaceutical Product Overview
11.10.3 Nordion Radiopharmaceutical Market Performance (2019-2024)
11.10.4 Nordion Business Overview
11.10.5 Recent Developments and Plans
11.11 IBA Group
11.11.1 IBA Group Company Profile
11.11.2 Radiopharmaceutical Product Overview
11.11.3 IBA Group Radiopharmaceutical Market Performance (2019-2024)
11.11.4 IBA Group Business Overview
11.11.5 Recent Developments and Plans
11.12 Jubilant Pharma
11.12.1 Jubilant Pharma Company Profile
11.12.2 Radiopharmaceutical Product Overview
11.12.3 Jubilant Pharma Radiopharmaceutical Market Performance (2019-2024)
11.12.4 Jubilant Pharma Business Overview
11.12.5 Recent Developments and Plans
12 Global Radiopharmaceutical Forecast Market Analysis by Type
12.1 Global Radiopharmaceutical Revenue Market Forecast by Type (2024-2030)
13 Global Radiopharmaceutical Forecast Market Analysis by Application
13.1 Radiopharmaceutical Revenue Market Forecast by Application (2024-2030)
14 Global Market Growth Forecast Analysis
14.1 Global Radiopharmaceutical Forecast Market Size (2024-2030)
14.2 Radiopharmaceutical Growth Trends Forecast Analysis by Regions
14.2.1 Radiopharmaceutical Revenue Forecast Market Size by Regions (2024-2030)
14.2.2 North America Radiopharmaceutical Forecast Market Size (2024-2030)
14.2.3 Europe Radiopharmaceutical Forecast Market Size (2024-2030)
14.2.4 Asia-Pacific Radiopharmaceutical Forecast Market Size (2024-2030)
14.2.5 Latin America Radiopharmaceutical Forecast Market Size (2024-2030)
14.2.6 Middle East & Africa Radiopharmaceutical Forecast Market Size (2024-2030)
15 Radiopharmaceutical Industry Dynamic Analysis
15.1 Radiopharmaceutical Market Trends Analysis
15.2 Radiopharmaceutical Market Drivers Analysis
15.3 Radiopharmaceutical Market Challenges Analysis
15.4 Radiopharmaceutical Market Restraints Analysis